Background: Current radiographic prognosticators of the outcome of Perthes disease can only be applied after femoral head deformity has occurred. Quantification of femoral head perfusion using the gadolinium-enhanced subtraction magnetic resonance imaging (MRI) technique may serve as an early prognosticator of outcome. The purposes of this study were 2-fold: (1) to develop a reliable method to quantify femoral head perfusion using this MRI technique; and (2) to determine whether the perfusion at early stages of Perthes disease correlates with radiographic deformity after a 2-year follow-up. Methods: A total of 20 patients meeting the following inclusion criteria were studied: radiographs and MRI obtained of femoral heads predeformity, age between 5 and 13 years, and unilateral disease. MR perfusion index, a measure of perfusion in the epiphysis, was obtained using digital image analysis of subtraction gadolinium-enhanced MRI. Intraobserver and interobserver agreement of this index was assessed by 2 independent observers. MR perfusion index was correlated with a radiographic deformity index (a measure of femoral head deformity) obtained after a minimum of 2 years. Results: The intraobserver agreement assessed by the intraclass correlation coefficient was 0.96 for observer 1 and 0.97 for observer 2. The interobserver agreement of the MR perfusion index was 0.90 for trials 1 and 2. MR perfusion index in the early stages of Perthes disease was highly variable, ranging from 0 to 0.70. After a minimum of 2 years following MRI acquisition, radiographs were obtained and evaluated using the deformity index, a continuous measure of femoral head deformity, by 2 blinded observers. Deformity index at 2-year follow-up showed moderate correlation with predeformity MR perfusion index (r = À0.56, P = 0.01, R 2 = 0.31). In those patients who were treated nonoperatively, the correlation was stronger (r = À0.79, P = 0.006, R 2 = 0.63).
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Conclusions: MR perfusion index obtained from gadoliniumenhanced subtraction MR images showed a high interobserver agreement. MR perfusion index is highly variable at early stages of Perthes disease, and a lower MR perfusion index correlated with greater radiographic deformity at the 2-year follow-up. This pilot study shows the promise of predeformity MR perfusion index as a possible early prognosticator of outcome in Perthes disease. Levels of Evidence: Prognostic level II. T he high variability of Legg-Calve-Perthes disease (LCPD) makes it difficult for physicians to determine prognosis and appropriate treatment. 1 The goal of treatment in LCPD is to minimize femoral head deformity, as long-term studies have shown that deformity leads to degenerative arthritis in >50% of patients in the sixth decade of life. 2 It is currently accepted that the main prognostic factors in LCPD are the age at onset of the disease, the extent of epiphyseal involvement, and the radiographic head-at-risk signs. 3 The Catterall classification was the first radiographic classification to recognize the importance of the amount of epiphyseal involvement in prognosis. 3, 4 Currently, the most commonly used radiographic classification systems to prognosticate outcome are the lateral pillar and Catterall classification systems. [3] [4] [5] However, these classification systems are limited as they cannot be applied until the fragmentation stage of the disease when significant deformity has already occurred. Early application of these classifications has been shown to lead to incorrect assignment and prognostication in some patients. 6, 7 Clearly, there is a need to develop a prognosticator that can be applied at early stages of LCPD before development of significant deformity.
In LCPD, a disruption of the femoral head perfusion is thought to be a key pathogenic event responsible for the femoral head osteonecrosis. [8] [9] [10] The extent of femoral head necrosis, however, is not uniform and has a prognostic significance. 3, 4 Conventional magnetic resonance imaging (MRI) (noncontrast MRI) has been suggested to more clearly delineate the extent of involvement compared with plain radiography or pinhole scintigraphy. 11, 12 Meanwhile, isolated cases of false-negative results from a conventional MRI have been reported in the initial stage of LCPD. 11, 13 Dynamic gadolinium-enhanced subtraction MRI, in contrast, has been shown to be more sensitive than radiography in detecting early ischemia and in correlating well with bone scintigraphy of the femoral head, as well as in depicting the extent of necrosis and revascularization more clearly. 14, 15 However, the relationship between the extent of the epiphyseal perfusion in the early stages of Perthes disease and the development of the femoral head deformity has not been investigated.
The purpose of this study was to develop a method of quantifying the extent of perfusion in the femoral head using gadolinium-enhanced MR images (MR perfusion index). Interobserver and intraobserver agreement of this method was assessed by 2 independent observers. The prognostic value of the MR perfusion index at early stages of LCPD was assessed by correlating it with the deformity index, a radiographic measure of femoral head deformity, at 2-year follow-up. We define early stages of LCPD using Waldenstrom staging, which divides the progression of the disease into 4 stages: stage of avascular necrosis (stage 1), stage of fragmentation (stage II), stage of reossification (stage III), and healed stage (stage IV). 16, 17 Only the patients in stage I or early stage II (before a significant fragmentation or deformity occurs) were included in this study. The deformity index is a continuous measure of femoral head deformity obtained at 2 years following the time of diagnosis that has been shown to correlate with Stulberg radiographic outcome at skeletal maturity. 18, 19 The deformity index is a ratio obtained by measuring the difference in the femoral head height and width between the affected and the normal head and dividing the sum of the differences by the width of the normal physis. Our goal was to develop a reliable method of quantifying early-stage femoral head perfusion and to assess its feasibility as a prognostic factor in the treatment of Perthes disease.
METHODS

Patients
Approval of this prospective study was obtained from our Institutional Review Board, and informed consent was obtained from all patients. Inclusion criteria for this study were: age between 5 and 13 years at the time of diagnosis, unilateral disease, and gadolinium-enhanced subtraction MR and radiographic images of the femoral head in stage I or early stage II Waldenstrom disease (stage of increased radiodensity or early fragmentation) before the lateral pillar or Catterall classifications can be applied. On average, 1.6 months (range, 0 to 3.4 mo) elapsed between initial diagnosis and MR image acquisition. Unilateral disease was a criterion because deformity index requires a normal contralateral hip for index determination.
Image Acquisition
Anterior-posterior radiographs and MR images were obtained of all 20 patients presenting with LCPD in Waldenstrom stage I and early stage II. MR images were acquired utilizing an 8-channel cardiac coil in a General Electric 1.5 Tesla scanner (Milwaukee, WI). Coronal fast spin echo (FSE) T1, and chemically fat-suppressed (FS) coronal FSE T1-weighted and T2-weighted images were obtained of both hips before intravenous (IV) gadolinium administration. Sagittal precontrast FS FSE T1-weighted images were also obtained. After the IV administration of 0.1 mmol/kg (maximum dose) of gadoteridol, FS coronal FSE T1-weighted images of both hips and FS sagittal FSE T1 of the affected hip were obtained with 4 mm slices and 1 mm gap. These postcontrast images were used to assess femoral head perfusion by subtracting the initial precontrast FS T1-weighted images increasing the conspicuity of the areas of abnormal perfusion. In this study, about 50% of patients required either sedation or general anesthesia. Younger patients (age below 8 y) generally required sedation or general anesthesia for the MRI, whereas older patients (age above 8 y) were imaged with video goggles alone. Anterior-posterior radiographs were subsequently obtained at minimum 2-year follow-up in all 20 patients.
Quantitative Image Analysis for MR Perfusion Index
The method for quantifying the MR perfusion index in the affected femoral head is shown in Figure 1 . Using digital image analysis software (Photoshop; Adobe Systems, San Jose, CA), the total area of the secondary ossification center and the total area of perfusion (gadolinium enhancement) within the secondary ossification center were obtained by measuring 6 to 8 serial MR images from each femoral head. To quantify the total area of the secondary ossification center, the outline of the secondary ossification center was traced using the T1 FS MR images. The area of the secondary ossification center was obtained in the number of pixels through the histogram window. To quantify the area of gadoliniumenhancement in the secondary ossification center, threshold segmentation was used on gadolinium-enhanced subtraction MR images. A threshold bar was shifted until only areas of gadolinium enhancement-that is, perfusion-were seen as white and the areas of nonenhancement as black. The number of white pixels was obtained through the histogram window. The sum of the area of perfusion in all serial images was divided by the sum of area of the secondary ossification center in all serial images to obtain the MR perfusion index.
Interobserver and Intraobserver Agreement for MR Perfusion Index
MR perfusion index was measured on 2 occasions after an interval of 2 weeks by 2 independent observers. Observers were blinded to any patient information and previous results.
Measuring Radiographic Deformity
Femoral head deformity was quantified 2 years after patients were diagnosed with LCPD using the deformity index, a radiographic measure of femoral head deformity that involves a ratio of the sum of the height and width of deformity to the length of the femoral neck of the unaffected femoral head. 18 Two independent observers were trained to measure the deformity index as described by Nelson and colleagues. Deformity index was measured on one occasion by both independent observers while blinded to any patient information for interobserver agreement.
Using the same set of radiographs, femoral head deformity was quantified using the epiphyseal quotient, which involves a ratio of epiphyseal height divided by epiphyseal width of the affected to the nonaffected femoral head. 20 Epiphyseal quotient was measured by 1 observer while blinded to any patient information.
Statistical Analysis
Interobserver and intraobserver agreements of MR perfusion index were assessed using the intraclass correlation coefficient. This test was also used to evaluate the interobserver agreement of the deformity index. The SAS/ STAT program version 9.2 was used. MR perfusion index was correlated with the deformity index using the nonparametric Spearman signed-rank correlation test. MR perfusion index was also correlated with epiphyseal quotient using the Spearman signed-rank correlation test. The correlation test between MR perfusion indices and deformity indices used values derived by averaging the data of 2 independent observers. In all correlation tests, P < 0.05 indicated statistical significance. The symbol " ± " indicates 1 SD above and below the mean.
RESULTS
Patient Data
A review of 41 patients prospectively enrolled in an MR study was conducted. Twenty-one patients did not meet the inclusion criteria: 7 patients presented with or developed bilateral disease, 1 patient was diagnosed with LCPD at an age outside of the inclusion range, IV access could not be obtained to administer gadolinium in 5 patients, and 8 patients had <2 years of minimum followup. Seventeen boys and 3 girls met the inclusion criteria. The average age at diagnosis was 8.6 ± 1.8 years (range, 5.7 to 12.5 y). Patients received either femoral osteotomy (n = 10) or nonoperative, symptomatic treatment (n = 10) depending on physician preference. In general, patients who received femoral osteotomy were older, with a mean age at diagnosis of 9.2 ± 1.7 years (range, 7 y 4 mo to 12 y 6 mo), compared with patients who received nonoperative treatments, who had a mean age at diagnosis of 7.9 ± 1.7 years (range, 5 y 8 mo to 11 y 2 mo). Nonoperative treatment consisted of physiotherapy, antiinflammatory medications, and activity modification. On average, femoral varus osteotomy was performed 1.5 months (range, 0 to 6 mo) after acquisition of MRI. In this image, the area of the epiphysis is 915 pixels. Six MR images in series were assessed, and areas of the secondary ossification center were summed to obtain a total area of 3856. B, A T1 coronal FS contrast-enhanced MR image obtained using the subtraction technique. Gadolinium-enhanced areas depicting perfusion are visible in gray. Nonenhanced areas depicting areas without perfusion are visible in black. C, The same image as (B) after threshold segmentation of the secondary ossification center. A threshold value bar was shifted until only enhanced areas (perfusion) were depicted as white pixels. In this image, the perfusion area is 315 pixels. Six MR images in series were assessed, and areas of perfusion were summed to obtain a total area of 887. The sum of pixels denoting perfusion (887) divided by the sum of pixels representing the secondary ossification center (3856) gives the MR perfusion index. In this case the index was 0.23.
Intraobserver and Interobserver Agreements
The intraobserver agreement for each observer was 0.96 and 0.97, respectively. The interobserver agreement was 0.90 for the first and 0.90 for the second trial of analyses. These results indicate high interobserver and intraobserver agreements.
Variability of MR Perfusion Index in Early-stage LCPD
In Waldenstrom stage I or early stage II, the average MR perfusion index was 0.21 ± 0.15 (range, 0 to 0.70). Although the femoral heads had similar radiographic appearance in the early stages of the disease, MR perfusion index varied substantially from one patient to another (Fig. 2) .
Correlation With Deformity
Deformity index was measured using radiographs obtained on average 2.4 ± 0.4 years (range, 2 to 3.1 y) after the time of diagnosis. Average deformity index at minimum 2-year follow-up was 0.33 ± 0.13 (range, 0.12 to 0.62). Interobserver agreement for deformity indices using intraclass correlation coefficient was 0.76. There was a moderate inverse correlation between the MR perfusion index and the deformity index, which was statistically significant by the Spearman rank correlation test (r = À 0.56, R 2 = 0.31, P = 0.01). A low MR perfusion index derived from gadolinium-enhanced subtraction MR images at early stages of the disease was associated with a high deformity index at 2-year follow-up, whereas a high MR perfusion index was associated with a low deformity index (Fig. 3) . For the 10 patients who received symptomatic nonoperative treatments, a stronger correlation was observed with r = À 0.79 (R 2 = 0.63, P = 0.006). For the 10 patients who received operative treatment, a weaker, nonsignificant correlation was observed with r = À 0.54 (P = 0.1).
Average epiphyseal quotient at 2-year follow-up was 0.47 ± 0.19 (range, 0.16 to 0.87). For the MR perfusion index and the epiphyseal quotient, the Spearman rank correlation test showed a statistically significant correlation of r = 0.47 (R 2 = 0.22, P = 0.04).
DISCUSSION
The variability in LCPD makes it difficult to prognosticate and determine candidates for operative treatments aimed at preventing or minimizing femoral head deformity. The lateral pillar and the Catterall classification systems can only be applied after significant femoral head deformity occurs. [4] [5] [6] [7] Ideally, a prognosticator that can be applied before this occurs would be optimal in guiding treatment decisions. The extent of subchondral fracture in the early stage of fragmentation has also been assessed for its prognostic value. 21 A major limitation of using subchondral fracture for prognostication, however, is that it may not be present in all patients presenting at the early stages of LCPD. In our series, only a limited number of patients presented with a subchondral fracture. In these limited cases, contrast enhancement was observed locally at the region of the fracture but did not extend to the rest of the epiphysis. We believe the local enhancement may be due to a granulation tissue invasion along the subchondral fracture, but we are not certain of this explanation.
To our knowledge, this is the first study to quantify perfusion at an early, prefragmentation stage of LCPD and to prospectively follow a cohort of patients to assess their radiographic outcome at a minimum 2-year followup. This study suggests that quantification of femoral head perfusion using gadolinium-enhanced subtraction MRI holds promise as a potential early prognostic tool. We found high variability of epiphyseal perfusion in early-stage LCPD according to the MR perfusion index. This indicates that the femoral heads are not equally involved at the early stage of the disease and that varying amounts of the femoral head remain viable, which is consistent with radiographic observations. 3, 4 It is clinically relevant that early MR perfusion index correlated significantly with femoral head deformity at a short term. Larger and long-term follow-up studies are warranted to further delineate the value of the MR perfusion index as an early prognosticator of outcome in LCPD.
The correlation between the MR perfusion and the deformity indices was statistically significant but moderate. This suggests that, although the extent of loss of perfusion in the femoral head at early stages may be an indicator of severity of the disease or influence the shortterm disease outcome, it is not the sole decider of shortterm outcome. Interestingly, when the results of the nonoperative treatment group alone were analyzed, the Spearman rank correlation test showed a higher correlation (r = À 0.79 for symptomatic treatment vs. r = À 0.56 for all patients). However, the correlation in the varus osteotomy group was less and became nonsignificant. One possible interpretation of this finding is that varus osteotomy improved the natural history of the disease, decreasing the correlation between the MR perfusion index and the deformity index. We did find a lower mean deformity index in the femoral varus osteotomy group (0.29 ± 0.13) compared with the nonoperative treatment group (0.38 ± 0.11). Although the difference was not statistically significant (P = 0.11), a type II error due to sample size cannot be ruled out.
The role of MRI in current management of LCPD is evolving as the MR techniques improve. 11, 22 Gadoliniumenhanced MRI is a sensitive modality for diagnosing LCPD at the early stages of the disease, with accuracy comparable to bone scintigraphy. 14 However, gadolinium-enhanced MRI can provide a greater accuracy in depicting necrosis and revascularization. MRI assessment of the physeal involvement has been shown to have a prognostic value in LCPD. 23 The use of gadolinium-enhanced MRI to predict outcome, however, has not been investigated. We hypothesized that the assessment of the femoral head perfusion using MRI in the early stages of the disease would be informative, as a disruption of blood flow to the femoral head is a key pathogenic event producing osteonecrosis in LCPD. 14, [24] [25] [26] [27] [28] [29] Various imaging studies have shown disruption of blood flow to the femoral head in LCPD. 14, 27, 30, 31 The Conway classification, which uses bone scintigraphy, has been shown to have good value as a prognosticator of eventual disease severity, but has been shown to have only moderate interobserver and intraobserver reliability. 32 In addition, use of radioactive isotopes and the inability to obtain cross-sectional imaging of the head limit the clinical application of bone scintigraphy. Gadoliniumenhanced subtraction MRI has been shown to not only have good agreement with bone scintigraphy but also depict the extent of necrosis more clearly and allow better visualization of the deformity and soft tissue alterations. 12, 15, 31 Thus, we elected to assess the role of this method in prognosticating a short-term outcome.
The key advantage of the MR perfusion index compared with the established radiographic prognostic classification systems is that it can be implemented at the initial stage of LCPD before any deformity has occurred, as it does not rely on femoral head fragmentation or the extent of deformity for classification. In addition, the MR perfusion index takes advantage of the ability of MRI to create a series of cross-sectional images that span from the anterior to the posterior region of the femoral head. Analysis of this series of images grants a more comprehensive evaluation of the parameter being studied, as opposed to radiographic methods that are limited to 2-dimensional analysis. The MRI technique, however, is time consuming as it requires proficiency with digital image analysis of multiple images for each patient. The ease-of-use of this method should improve as the software and the MR techniques in quantifying the areas of contrast enhancement improve. For now, a visual estimation of perfusion can be obtained by a radiologist and can provide a quick indication of the extent of the femoral head involvement. A precaution should be taken when a gadolinium-based contrast agent is used, as it has been associated with nephrogenic systemic fibrosis in certain patients with kidney disease (acute kidney injury or chronic, severe kidney disease with a glomerular filtration rate of <30 mL/min/1.73 m 2 ). 33, 34 Nephrogenic systemic fibrosis, however, has not been reported in patients with normal kidney function. We routinely screen our patients before gadolinium administration for history of renal disease as a precaution.
The use of gadolinium-enhanced subtraction MRI to assess femoral head involvement in LCPD is relatively new and its indications are not well defined at this time. This is one of the reasons why this study had a wide age range of patients. Going forward, it will be important to investigate the prognostic value of gadolinium-enhanced subtraction MRI in different age groups of patients (ie, early-onset vs. late-onset LCPD), which this study was not able to decipher because of its relatively small sample size. Currently, we are in the process of organizing a multicenter prospective study to investigate the prognostic role of perfusion MRI for various age groups with a larger number of patients over a longer period of time. Other relevant investigations to perform would include serial perfusion MRI to study the reperfusion pattern of the femoral head as LCPD progresses and to quantitatively assess the level of perfusion in the affected and the normal hips as we did not assess the difference in this study.
This study does have several limitations. One significant limitation of the study is that although we assessed the intraobserver and interobserver agreement of the MR perfusion index, we did not study the reproducibility of MR perfusion as a test. Further, the accuracy of the MR perfusion index was not compared with a gold standard. One difficulty with such a comparison, however, is that there is no established gold standard for femoral head perfusion in LCPD. Another limitation of the study is a small sample size. Despite this limitation, statistical significance was obtained in the correlation of MR perfusion index and 2-year deformity index and epiphyseal quotient. Moreover, given relatively recent application of the subtraction MRI in the patients with LCPD, a long-term follow-up study could not be conducted at this time. Bilateral cases of LCPD were excluded because the deformity index and epiphyseal quotient require an unaffected femoral head for comparison. Although these indices of radiographic deformity are limited in this regard, they are both continuous variables, allowing for continuous regression analysis with the MR perfusion.
In conclusion, MR perfusion index obtained from gadolinium-enhanced subtraction MR images showed a high interobserver agreement. The MR perfusion index is highly variable at early stages of Perthes disease, and a lower MR perfusion index correlated with greater radiographic deformity at 2-year follow-up. The MR perfusion index is promising as an early prognostic tool that should be further studied for clinical applicability.
